NYSE$CLB

Core Laboratories Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

CLB Q1 2024 — CAD 96.5M revenue

In the opinion of management, all adjustments considered necessary for a fair statement of the results for the interim periods presented have been included in these financial statements. Core Laboratories Inc reported Q1 2024 results. Net income of CAD 1.0M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.

  • Revenue: CAD 96.5M.
  • Net income: CAD 1.0M.
  • Operating income: CAD 9K.

Headline financials

Total Revenue

$130M

No prior period
EPS

$0.07

No prior period
Capital Expenditures

-$3.05M

No prior period
Free Cash Flow

$168K

No prior period
Net Income

$3.22M

No prior period
Operating Income

$8.57M

No prior period
Gross Profit

$757K

No prior period
Cash & Equivalents

$14.9M

No prior period
Total Assets

$588M

No prior period

Revenue & EPS history

Core Labs · Revenue · Quarterly

$130M

Q1 2024
Beat estimate in 1 of 2 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 9 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+4.1%

Avg return

Earnings day

+2.8%

Avg return

5 days after

-3.7%

Avg return

30 days after

67%

6 / 9 earnings

Positive

+28.8%

Q3 2025

Best reaction

-15.3%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-15.3%-17.7%-21.2%
Q4 2025-4.2%-4.9%-18.9%
Q3 2025+28.8%+29.0%+15.3%
Q1 2025+2.2%-2.1%-6.5%
Q3 2024+10.9%+14.2%+24.6%
Q2 2024+10.6%+11.2%-16.6%
Q1 2024+3.3%-4.4%+8.4%
Q3 2023+1.1%-10.8%-14.0%
Q2 2023-0.8%+10.6%-4.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro